Abdominal aortic aneurysm (AAA) causes∼ 170 000 deaths annually worldwide. Most
guidelines recommend asymptomatic small AAAs (30 to< 50 mm in women; 30 to< 55 mm in …

Abstract Objective The European Society for Vascular Surgery (ESVS) has developed
clinical practice guidelines for the care of patients with aneurysms of the abdominal aorta …

Introduction For a long time, metformin has been the first-line treatment for glycemic control
in type 2 diabetes; however, the results of recent cardiovascular outcome trials of sodium …

Aortic aneurysms, including abdominal aortic aneurysms (AAAs), is the second most
prevalent aortic disease and represents an important cause of death worldwide. AAA is a …

Aortic aneurysm is a vascular disease characterized by irreversible vasodilatation that can
lead to dissection and rupture of the aortic aneurysm, a life-threatening condition. Thoracic …

Studies have shown that diabetes mellitus is associated with a reduced prevalence and
growth of abdominal aortic aneurysms (AAA). Establishing the factors that influence AAA …

Purpose: Metformin, widely used for the treatment of diabetes mellitus (DM), has shown
potential for inhibiting abdominal aortic aneurysm (AAA) growth by reducing extracellular …

Objective Current literature reports conflicting findings regarding the effect of diabetes
mellitus (DM) on outcomes of AAA repair. In this study we examined the effect of DM and its …

Introduction An abdominal aortic aneurysm (AAA) is a swelling of the main artery in the body
estimated to affect 0.92% of adults (aged 30-79) worldwide. Rupture is often fatal and …

Rupture or dissection of the aorta is often fatal. Tcheandjieu and colleagues now identify key
pathways underlying aortic dilatation, a common prelude to acute aortic events, and assess …